Skip to main content

Viela Bio clears another hurdle to get rare disease drug to market – Washington Business Journal

By September 3, 2019News
viela-bio-logo

viela-bio-logo

The rare autoimmune disease compromises the central nervous system.

{iframe}https://www.bizjournals.com/washington/news/2019/08/27/viela-bio-clears-another-hurdle-to-get-rare.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.